Newsroom

Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

12/5/2018, Wednesday

Bausch + Lomb Receives 510(K) Clearance From FDA FOR Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses

12/4/2018, Tuesday

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

11/15/2018, Thursday

Bausch + Lomb Reports More Than Five Million Units of Contact Lens Materials Recycled by Second Anniversary of ONE by ONE Recycling Program

11/6/2018, Tuesday

Bausch + Lomb to Present New Scientific Data During the American Academy of Optometry Meeting in San Antonio

10/24/2018, Wednesday

Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite™ Vision Enhancement System on IBM Cloud

10/24/2018, Wednesday

Bausch + Lomb Invites Surgeons to Experience First-in-Class eyeTELLIGENCE™ Applications on Stellaris Elite™ Vision Enhancement System During the American Academy of Ophthalmology Meeting in Chicago

10/16/2018, Tuesday

Bausch + Lomb Announces Completion of 100th Clinical Case Using Vitesse® Hypersonic Vitrectomy System on Stellaris Elite™ Vision Enhancement System

9/10/18, Monday

LUMIFY™ Redness Reliever Eye Drops Honored by The National Association of Chain Drug Stores as Product Showcase Winner

9/5/2018, Wednesday

Bausch + Lomb Announces Publication of Pivotal Phase 3 Data on Loteprednol Etabonate Ophthalmic Gel, 0.38% in Journal of Cataract and Refractive Surgery

8/27/2018, Monday

Bausch + Lomb Launches Expanded Parameters of Biotrue® ONEday for Astigmatism Contact Lenses 

8/20/2018

Joseph Gordon Named U.S. President of Bausch + Lomb

7/24/2018, Tuesday

Bausch + Lomb Relocates Company Archive to New Space in Rochester, NY Optics Center Facility, Showcasing 165 Years of Science and Innovation

7/9/2018, Monday

Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

6/25/2018, Monday

Bausch + Lomb Announces Licensing Agreement With Tangible Science For Use of Tangible Hydra-Peg Custom Contact Lens Coating Technology

6/18/2018, Monday

Bausch + Lomb Launches -2.75D Cylinder Power for Bausch + Lomb ULTRA® for Astigmatism Contact Lenses, the Fastest Growing Family of Monthly Planned Replacement Lenses

6/18/2018, Monday

Bausch + Lomb Receives FDA Pre-Market Approval For enVista® Toric MX60T Intraocular Lens

6/14/2018, Thursday

Bausch + Lomb Announces US Launch of Soothe® Xtra Protection Preservative Free Lubricant Eye Drops

6/12/2018, Tuesday

Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins

6/4/2018, Monday

Bausch + Lomb Enrolls First Patient in enVista® MX60EF Trifocal IOL Clinical Trial

5/9/2018, Wednesday

Bausch + Lomb Initiates Clincal Trial Evaluating New Ophthalmic Viscosurgical Device (OVD)

1234567Last